ABT · Categories · Form 4
ABT - SEC Form 4 insider transactions
Abbott Laboratories (ABT) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for ABT
- SEC Form 4 filed by EXECUTIVE VICE PRESIDENT Moreland Mary K4 - ABBOTT LABORATORIES (0000001800) (Issuer)
- Director Conroy Kevin T was granted 2,286 units of Common shares without par value, increasing direct ownership by 2% to 133,737 units (SEC Form 4)4 - ABBOTT LABORATORIES (0000001800) (Issuer)
- Director Stratton John G was granted 2,286 units of Common shares without par value, increasing direct ownership by 12% to 21,319 units (SEC Form 4)4 - ABBOTT LABORATORIES (0000001800) (Issuer)
- Director Roman Michael F was granted 2,286 units of Common shares without par value, increasing direct ownership by 27% to 10,764 units (SEC Form 4)4 - ABBOTT LABORATORIES (0000001800) (Issuer)
- Director O'Grady Michael was granted 2,286 units of Common shares without par value, increasing direct ownership by 43% to 7,603 units (SEC Form 4)4 - ABBOTT LABORATORIES (0000001800) (Issuer)
- Director Mckinstry Nancy was granted 2,286 units of Common shares without par value, increasing direct ownership by 6% to 41,010 units (SEC Form 4)4 - ABBOTT LABORATORIES (0000001800) (Issuer)
- Director Mcdew Darren W was granted 2,286 units of Common shares without par value, increasing direct ownership by 22% to 12,678 units (SEC Form 4)4 - ABBOTT LABORATORIES (0000001800) (Issuer)
- Director Kumbier Michelle was granted 2,286 units of Common shares without par value, increasing direct ownership by 15% to 18,000 units (SEC Form 4)4 - ABBOTT LABORATORIES (0000001800) (Issuer)
- Director Gonzalez Patricia Paola was granted 2,286 units of Common shares without par value, increasing direct ownership by 33% to 9,205 units (SEC Form 4)4 - ABBOTT LABORATORIES (0000001800) (Issuer)
- Director Blount Sally E. was granted 2,286 units of Common shares without par value, increasing direct ownership by 7% to 36,344 units (SEC Form 4)4 - ABBOTT LABORATORIES (0000001800) (Issuer)
- Director Babineaux-Fontenot Claire was granted 2,286 units of Common shares without par value, increasing direct ownership by 43% to 7,603 units (SEC Form 4)4 - ABBOTT LABORATORIES (0000001800) (Issuer)
- Director Ahuja Nita was granted 2,286 units of Common shares without par value (SEC Form 4)4 - ABBOTT LABORATORIES (0000001800) (Issuer)
- SEC Form 4 filed by Stratton John G4 - ABBOTT LABORATORIES (0000001800) (Issuer)
- SEC Form 4 filed by Roman Michael F4 - ABBOTT LABORATORIES (0000001800) (Issuer)
- SEC Form 4 filed by Gonzalez Patricia Paola4 - ABBOTT LABORATORIES (0000001800) (Issuer)
- SEC Form 4 filed by Alpern Robert J4 - ABBOTT LABORATORIES (0000001800) (Issuer)
- SEC Form 4 filed by Ahuja Nita4 - ABBOTT LABORATORIES (0000001800) (Issuer)
- SEC Form 4 filed by Orville Jacob A4 - ABBOTT LABORATORIES (0000001800) (Issuer)
- Senior Vice President Shroff Eric covered exercise/tax liability with 1,384 units of Common shares without par value and sold $81,946 worth of Common shares without par value (709 units at $115.58), decreasing direct ownership by 5% to 39,164 units (SEC Form 4)4 - ABBOTT LABORATORIES (0000001800) (Issuer)
- EXECUTIVE VICE PRESIDENT Scoggins Christopher J covered exercise/tax liability with 4,997 units of Common shares without par value, decreasing direct ownership by 6% to 77,126 units (SEC Form 4)4 - ABBOTT LABORATORIES (0000001800) (Issuer)
- EVP AND GROUP PRESIDENT Salvadori Daniel Gesua Sive covered exercise/tax liability with 6,615 units of Common shares without par value and sold $102,288 worth of Common shares without par value (885 units at $115.58), decreasing direct ownership by 5% to 146,377 units (SEC Form 4)4 - ABBOTT LABORATORIES (0000001800) (Issuer)
- EXECUTIVE VICE PRESIDENT Morrone Louis H. covered exercise/tax liability with 4,040 units of Common shares without par value and sold $132,224 worth of Common shares without par value (1,144 units at $115.58), decreasing direct ownership by 6% to 76,843 units (SEC Form 4)4 - ABBOTT LABORATORIES (0000001800) (Issuer)
- EXECUTIVE VICE PRESIDENT Moreland Mary K covered exercise/tax liability with 4,630 units of Common shares without par value and sold $70,851 worth of Common shares without par value (613 units at $115.58), decreasing direct ownership by 5% to 104,291 units (SEC Form 4)4 - ABBOTT LABORATORIES (0000001800) (Issuer)
- VICE PRESIDENT AND CONTROLLER Mccoy John A. Jr. covered exercise/tax liability with 1,142 units of Common shares without par value and sold $67,614 worth of Common shares without par value (585 units at $115.58), decreasing direct ownership by 7% to 24,628 units (SEC Form 4)4 - ABBOTT LABORATORIES (0000001800) (Issuer)
- CHAIRMAN AND CEO Ford Robert B covered exercise/tax liability with 30,308 units of Common shares without par value, decreasing direct ownership by 9% to 306,461 units (SEC Form 4)4 - ABBOTT LABORATORIES (0000001800) (Issuer)
- EVP AND GROUP PRESIDENT Earnhardt Lisa D covered exercise/tax liability with 8,577 units of Common shares without par value, decreasing direct ownership by 9% to 90,407 units (SEC Form 4)4 - ABBOTT LABORATORIES (0000001800) (Issuer)
- EVP, GC AND SECRETARY Cushman Elizabeth C. covered exercise/tax liability with 1,421 units of Common shares without par value and sold $30,398 worth of Common shares without par value (263 units at $115.58), decreasing direct ownership by 4% to 38,573 units (SEC Form 4)4 - ABBOTT LABORATORIES (0000001800) (Issuer)
- EVP AND CFO Boudreau Philip P covered exercise/tax liability with 7,441 units of Common shares without par value, decreasing direct ownership by 9% to 71,172 units (SEC Form 4)4 - ABBOTT LABORATORIES (0000001800) (Issuer)
- Senior Vice President Shroff Eric was granted 10,873 units of Common shares without par value, increasing direct ownership by 36% to 41,257 units (SEC Form 4)4 - ABBOTT LABORATORIES (0000001800) (Issuer)
- EXECUTIVE VICE PRESIDENT Scoggins Christopher J was granted 18,502 units of Common shares without par value, increasing direct ownership by 29% to 82,123 units (SEC Form 4)4 - ABBOTT LABORATORIES (0000001800) (Issuer)
- EVP AND GROUP PRESIDENT Salvadori Daniel Gesua Sive was granted 21,644 units of Common shares without par value, increasing direct ownership by 16% to 153,877 units (SEC Form 4)4 - ABBOTT LABORATORIES (0000001800) (Issuer)
- EXECUTIVE VICE PRESIDENT Morrone Louis H. was granted 15,418 units of Common shares without par value, increasing direct ownership by 23% to 82,027 units (SEC Form 4)4 - ABBOTT LABORATORIES (0000001800) (Issuer)
- EXECUTIVE VICE PRESIDENT Moreland Mary K was granted 13,951 units of Common shares without par value, increasing direct ownership by 15% to 109,534 units (SEC Form 4)4 - ABBOTT LABORATORIES (0000001800) (Issuer)
- VICE PRESIDENT AND CONTROLLER Mccoy John A. Jr. was granted 5,373 units of Common shares without par value, increasing direct ownership by 26% to 26,355 units (SEC Form 4)4 - ABBOTT LABORATORIES (0000001800) (Issuer)
- CHAIRMAN AND CEO Ford Robert B was granted 83,464 units of Common shares without par value, increasing direct ownership by 33% to 336,769 units (SEC Form 4)4 - ABBOTT LABORATORIES (0000001800) (Issuer)
- EVP AND GROUP PRESIDENT Earnhardt Lisa D was granted 27,056 units of Common shares without par value, increasing direct ownership by 38% to 98,984 units (SEC Form 4)4 - ABBOTT LABORATORIES (0000001800) (Issuer)
- EVP, GC AND SECRETARY Cushman Elizabeth C. was granted 15,031 units of Common shares without par value, increasing direct ownership by 60% to 40,257 units (SEC Form 4)4 - ABBOTT LABORATORIES (0000001800) (Issuer)
- EVP AND CFO Boudreau Philip P was granted 27,997 units of Common shares without par value, increasing direct ownership by 55% to 78,613 units (SEC Form 4)4 - ABBOTT LABORATORIES (0000001800) (Issuer)
- SEC Form 4 filed by Director Stratton John G4 - ABBOTT LABORATORIES (0000001800) (Issuer)
- SEC Form 4 filed by Director Roman Michael F4 - ABBOTT LABORATORIES (0000001800) (Issuer)
- SEC Form 4 filed by Director Gonzalez Patricia Paola4 - ABBOTT LABORATORIES (0000001800) (Issuer)
- SEC Form 4 filed by Director Alpern Robert J4 - ABBOTT LABORATORIES (0000001800) (Issuer)
- EVP AND GROUP PRESIDENT Salvadori Daniel Gesua Sive gifted 1,536 units of Common shares without par value, decreasing direct ownership by 1% to 132,233 units (SEC Form 4)4 - ABBOTT LABORATORIES (0000001800) (Issuer)
- Senior Vice President Shroff Eric sold $203,043 worth of Common shares without par value (1,586 units at $128.02), decreasing direct ownership by 5% to 30,384 units (SEC Form 4)4 - ABBOTT LABORATORIES (0000001800) (Issuer)
- SEC Form 4 filed by Director Stratton John G4 - ABBOTT LABORATORIES (0000001800) (Issuer)
- SEC Form 4 filed by Director Roman Michael F4 - ABBOTT LABORATORIES (0000001800) (Issuer)
- SEC Form 4 filed by Director Gonzalez Patricia Paola4 - ABBOTT LABORATORIES (0000001800) (Issuer)
- SEC Form 4 filed by Director Alpern Robert J4 - ABBOTT LABORATORIES (0000001800) (Issuer)
- VICE PRESIDENT AND CONTROLLER Mccoy John A. Jr. covered exercise/tax liability with 79 units of Common shares without par value, decreasing direct ownership by 0.38% to 20,982 units (SEC Form 4)4 - ABBOTT LABORATORIES (0000001800) (Issuer)
- EVP AND CFO Boudreau Philip P covered exercise/tax liability with 387 units of Common shares without par value, decreasing direct ownership by 0.76% to 50,616 units (SEC Form 4)4 - ABBOTT LABORATORIES (0000001800) (Issuer)
- EVP AND CFO Boudreau Philip P sold $746,758 worth of Common shares without par value (5,550 units at $134.55), decreasing direct ownership by 10% to 51,003 units (SEC Form 4)4 - ABBOTT LABORATORIES (0000001800) (Issuer)
- SEC Form 4 filed by Director Stratton John G4 - ABBOTT LABORATORIES (0000001800) (Issuer)
- SEC Form 4 filed by Director Roman Michael F4 - ABBOTT LABORATORIES (0000001800) (Issuer)
- SEC Form 4 filed by Director Gonzalez Patricia Paola4 - ABBOTT LABORATORIES (0000001800) (Issuer)
- SEC Form 4 filed by Director Alpern Robert J4 - ABBOTT LABORATORIES (0000001800) (Issuer)
- EXECUTIVE VICE PRESIDENT Morrone Louis H. covered exercise/tax liability with 269 units of Common shares without par value, decreasing direct ownership by 0.40% to 66,609 units (SEC Form 4)4 - ABBOTT LABORATORIES (0000001800) (Issuer)
- EVP, GC AND SECRETARY Cushman Elizabeth C. was granted 3,790 units of Common shares without par value, increasing direct ownership by 18% to 25,226 units (SEC Form 4)4 - ABBOTT LABORATORIES (0000001800) (Issuer)
- Director Blount Sally E. sold $337,116 worth of Common shares without par value (2,600 units at $129.66), decreasing direct ownership by 7% to 34,058 units (SEC Form 4)4 - ABBOTT LABORATORIES (0000001800) (Issuer)
- Director Stratton John G was granted 1,635 units of Common shares without par value, increasing direct ownership by 9% to 19,033 units (SEC Form 4)4 - ABBOTT LABORATORIES (0000001800) (Issuer)
- Director Starks Daniel J was granted 1,635 units of Common shares without par value, increasing direct ownership by 0.02% to 6,728,817 units (SEC Form 4)4 - ABBOTT LABORATORIES (0000001800) (Issuer)